SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-012491
Filing Date
2022-05-16
Accepted
2022-05-16 09:15:50
Documents
70
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20220331_10q.htm   iXBRL 10-Q 1345475
2 EXHIBIT 31.1 ex_374813.htm EX-31.1 7887
3 EXHIBIT 31.2 ex_374814.htm EX-31.2 7993
4 EXHIBIT 32.1 ex_374815.htm EX-32.1 5908
  Complete submission text file 0001437749-22-012491.txt   5835501

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA acrx-20220331.xsd EX-101.SCH 58914
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20220331_cal.xml EX-101.CAL 36861
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20220331_def.xml EX-101.DEF 358966
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20220331_lab.xml EX-101.LAB 340278
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20220331_pre.xml EX-101.PRE 388985
64 EXTRACTED XBRL INSTANCE DOCUMENT acrx20220331_10q_htm.xml XML 834732
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 22925949
SIC: 2834 Pharmaceutical Preparations